no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein A30P+A53T transgenic mice
|
Ono, Kazuhiko |
|
2009 |
15 |
Supplement 4 |
p. 649-654 6 p. |
article |
2 |
Announcement
|
|
|
2009 |
15 |
Supplement 4 |
p. 482- 1 p. |
article |
3 |
Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease]
|
Chaná, Pedro |
|
2009 |
15 |
Supplement 4 |
p. S22-S25 4 p. |
article |
4 |
Clinimetric analyses of the Modified Parkinson Activity Scale
|
Keus, S.H.J. |
|
2009 |
15 |
Supplement 4 |
p. 263-269 7 p. |
article |
5 |
Compound heterozygosity in DJ-1 gene non-coding portion related to parkinsonism
|
Tarantino, Patrizia |
|
2009 |
15 |
Supplement 4 |
p. 324-326 3 p. |
article |
6 |
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
|
Kalaitzakis, M.E. |
|
2009 |
15 |
Supplement 4 |
p. 196-204 9 p. |
article |
7 |
Does melatonin help save dopaminergic cells in MPTP-treated mice?
|
Ma, Jeannine |
|
2009 |
15 |
Supplement 4 |
p. 307-314 8 p. |
article |
8 |
Dopamine receptor agonists and sleep disturbances in Parkinson's disease
|
Chaudhuri, K. Ray |
|
2009 |
15 |
Supplement 4 |
p. S101-S104 4 p. |
article |
9 |
Excessive daytime sleepiness in cervical dystonia
|
Trotti, Lynn Marie |
|
2009 |
15 |
Supplement 4 |
p. 784-786 3 p. |
article |
10 |
Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
|
Hasegawa, Kazuko |
|
2009 |
15 |
Supplement 4 |
p. 300-306 7 p. |
article |
11 |
Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics
|
Ross, Christopher A. |
|
2009 |
15 |
Supplement 4 |
p. S135-S138 4 p. |
article |
12 |
Iron transport in Parkinson's disease
|
Hirsch, E.C. |
|
2009 |
15 |
Supplement 4 |
p. S209-S211 3 p. |
article |
13 |
Levodopa therapeutics for Parkinson's disease: new developments
|
LeWitt, Peter A. |
|
2009 |
15 |
Supplement 4 |
p. S31-S34 4 p. |
article |
14 |
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
|
Grégoire, Laurent |
|
2009 |
15 |
Supplement 4 |
p. 445-452 8 p. |
article |
15 |
Mild cognitive impairment in Parkinson's disease
|
Adler, Charles H. |
|
2009 |
15 |
Supplement 4 |
p. S81-S82 2 p. |
article |
16 |
Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease
|
Bardien, Soraya |
|
2009 |
15 |
Supplement 4 |
p. 116-121 6 p. |
article |
17 |
Motor overflow and mirror dystonia
|
Sitburana, Oraporn |
|
2009 |
15 |
Supplement 4 |
p. 758-761 4 p. |
article |
18 |
Neuroinflammation in the living brain of Parkinson's disease
|
Ouchi, Yasuomi |
|
2009 |
15 |
Supplement 4 |
p. S200-S204 5 p. |
article |
19 |
O.059 Are growth factors the answer in Parkinson's disease?
|
Barker, R. |
|
2009 |
15 |
Supplement 4 |
p. S15-S16 2 p. |
article |
20 |
Octarepeat changes of prion protein in Parkinson's disease
|
Wang, Vinchi |
|
2009 |
15 |
Supplement 4 |
p. 53-58 6 p. |
article |
21 |
O.073 Current understanding of myoclonus
|
Caviness, J. |
|
2009 |
15 |
Supplement 4 |
p. S19- 1 p. |
article |
22 |
O.045 Mechanisms of dystonia
|
Standaert, D. |
|
2009 |
15 |
Supplement 4 |
p. S12- 1 p. |
article |
23 |
O.076 Medical management of early Parkinson's disease
|
Hauser, R. |
|
2009 |
15 |
Supplement 4 |
p. S20- 1 p. |
article |
24 |
O.100 New targets for DBS: can DBS modulate non-motor symptoms?
|
Moro, E. |
|
2009 |
15 |
Supplement 4 |
p. S26- 1 p. |
article |
25 |
O.011 Psychogenic movement disorders
|
Jankovic, J. |
|
2009 |
15 |
Supplement 4 |
p. S4- 1 p. |
article |
26 |
O.028 The spectrum of clinical manifestations of basal ganglia disorders: a challenge for any new model
|
Obeso, J. |
|
2009 |
15 |
Supplement 4 |
p. S8- 1 p. |
article |
27 |
O.086 Treatment of dysautonomia associated with Parkinson's disease
|
Jankovic, J. |
|
2009 |
15 |
Supplement 4 |
p. S22- 1 p. |
article |
28 |
O.042 Ultrasound in sialorrhea treatment in Parkinson's patients
|
Truong, D. |
|
2009 |
15 |
Supplement 4 |
p. S12- 1 p. |
article |
29 |
P2.213 Ab amyloid deposits are common in brains of non-demented PD patients
|
Gomperts, S. |
|
2009 |
15 |
Supplement 4 |
p. S147- 1 p. |
article |
30 |
P3.144 Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of Parkinsonian rats
|
Szkilnik, R. |
|
2009 |
15 |
Supplement 4 |
p. S185- 1 p. |
article |
31 |
P2.118 Allosteric modulation of group III metabotropic glutamate receptor 4: a potential neuroprotective approach for the treatment of Parkinson's disease
|
Betts, M. |
|
2009 |
15 |
Supplement 4 |
p. S121- 1 p. |
article |
32 |
P2.004 Amygdala stimulation is not able to rescues the long-term potentiation (LTP) at the depotentiation synapses in the dentate gyrus
|
Duany, C. |
|
2009 |
15 |
Supplement 4 |
p. S89- 1 p. |
article |
33 |
P2.151 Anticholinergics for axial symptoms in Parkinson's disease with subthalamic nucleus stimulation
|
Onozawa, R. |
|
2009 |
15 |
Supplement 4 |
p. S130- 1 p. |
article |
34 |
P1.010 A proactive approach to falls in Parkinson's disease
|
Grantier, L.L. |
|
2009 |
15 |
Supplement 4 |
p. S31- 1 p. |
article |
35 |
P1.082 A retrospective assessment of physical, cognitive, and affective factors that relate to falls in individuals with Parkinson's disease
|
Masterson, M. |
|
2009 |
15 |
Supplement 4 |
p. S50- 1 p. |
article |
36 |
Parkin gene therapy
|
Mochizuki, Hideki |
|
2009 |
15 |
Supplement 4 |
p. S43-S45 3 p. |
article |
37 |
P1.216 Arytenoid tremor predicts severity of glottic stenosis in multiple system atrophy
|
Ozawa, T. |
|
2009 |
15 |
Supplement 4 |
p. S84-S85 2 p. |
article |
38 |
P2.021 Astrocytes: central role in Parkinson's pathology?
|
Schmidt, S. |
|
2009 |
15 |
Supplement 4 |
p. S93-S94 2 p. |
article |
39 |
P1.161 Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?
|
Sarwar, A. |
|
2009 |
15 |
Supplement 4 |
p. S70- 1 p. |
article |
40 |
P1.113 Brain monoamine systems in multiple system atrophy: a positron emission tomography study
|
Pavese, N. |
|
2009 |
15 |
Supplement 4 |
p. S58- 1 p. |
article |
41 |
P3.058 Ceruloplasmin is involved in the nigral iron accumulation of 6-OHDA lesioned rats
|
Wang, J. |
|
2009 |
15 |
Supplement 4 |
p. S163- 1 p. |
article |
42 |
P2.124 Changes in quality of life and nocturnal symptoms in sleep-impaired patients with advanced Parkinson's disease treated with ropinirole prolonged release
|
Martinez-Martin, P. |
|
2009 |
15 |
Supplement 4 |
p. S123- 1 p. |
article |
43 |
P1.202 Changes of procedural learning in patients with Wilson disease
|
Wang, X.-P. |
|
2009 |
15 |
Supplement 4 |
p. S81- 1 p. |
article |
44 |
P1.007 Charcot's contribution to the study of Tourette's syndrome
|
Teive, H. |
|
2009 |
15 |
Supplement 4 |
p. S30- 1 p. |
article |
45 |
P1.099 Color discrimination impairment with patients with Parkinson's disease and their regional cerebral blood flow changes
|
Watanabe, M. |
|
2009 |
15 |
Supplement 4 |
p. S54- 1 p. |
article |
46 |
P2.182 Coping and quality of life in Parkinson disease: the deep brain stimulation effect
|
Montel, S. |
|
2009 |
15 |
Supplement 4 |
p. S139- 1 p. |
article |
47 |
P2.035 Deep brain stimulation effects on orthostatic regulations in patients with Parkinson's disease
|
Hou, J.G. |
|
2009 |
15 |
Supplement 4 |
p. S97-S98 2 p. |
article |
48 |
P1.175 Deflning a test score for status assessment during motor fluctuations in Parkinson's disease
|
Westin, J. |
|
2009 |
15 |
Supplement 4 |
p. S74- 1 p. |
article |
49 |
P3.106 Dendritic cell vaccine against human a-synuclein aggregates
|
Cao, C. |
|
2009 |
15 |
Supplement 4 |
p. S175- 1 p. |
article |
50 |
P1.144 Different effects between acupuncture and anti-parkinsonian medicine on the cortical excitability in patients with Parkinson's disease
|
Lin, Y.C. |
|
2009 |
15 |
Supplement 4 |
p. S65-S66 2 p. |
article |
51 |
P3.178 Does quetiapine improve REM sleep behavior disorder (RBD) in Parkinson's disease? 3 case reports
|
Carvalho, D. |
|
2009 |
15 |
Supplement 4 |
p. S194- 1 p. |
article |
52 |
P2.165 Dose-related decrease in “off” time with ropinirole prolonged release in patients with advanced Parkinson's disease
|
Stocchi, F. |
|
2009 |
15 |
Supplement 4 |
p. S134-S135 2 p. |
article |
53 |
P3.192 Effect of bilateral globus pallidus internus deep brain stimulation on periodic limb movements in Parkinson's disease patient and possible mechanism
|
Lyons, M. |
|
2009 |
15 |
Supplement 4 |
p. S197- 1 p. |
article |
54 |
P3.161 Effect of physical rehabilitation on perceived quality of life of persons with Parkinson disease
|
Dobi, D. |
|
2009 |
15 |
Supplement 4 |
p. S189- 1 p. |
article |
55 |
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity
|
Chou, Kelvin L. |
|
2009 |
15 |
Supplement 4 |
p. 640-643 4 p. |
article |
56 |
P2.110 Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease
|
Hamza, T. |
|
2009 |
15 |
Supplement 4 |
p. S119- 1 p. |
article |
57 |
P2.096 Exendin-4 potentiates L-DOPA-evoked DA release in rat striatum
|
Abuirmeileh, A. |
|
2009 |
15 |
Supplement 4 |
p. S114-S115 2 p. |
article |
58 |
P2.154 Exendin-4 promotes recovery of both behavioral and neurochemical deflcits in a “pre-motor” rodent model of Parkinson's disease
|
Rampersaud, N. |
|
2009 |
15 |
Supplement 4 |
p. S131- 1 p. |
article |
59 |
P1.041 Factor structure of the Geriatric Depression Scale in Turkish Parkinson's disease patients
|
Ertan, T. |
|
2009 |
15 |
Supplement 4 |
p. S39- 1 p. |
article |
60 |
P2.014 Gait analysis in a porcine model of progressive Parkinson disease established by chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication
|
Mogensen, P. |
|
2009 |
15 |
Supplement 4 |
p. S91-S92 2 p. |
article |
61 |
P3.134 Infectious causes of parkinsonism
|
Munhoz, R. |
|
2009 |
15 |
Supplement 4 |
p. S182- 1 p. |
article |
62 |
P1.058 Intracranial granulomas presenting as extrapyramidal disorder: a report of three cases
|
Jha, S. |
|
2009 |
15 |
Supplement 4 |
p. S43-S44 2 p. |
article |
63 |
P1.110 123I-/V-cu-fluoro-propyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([123I] FP-CIT) SPECT in cases of multiple system atrophy
|
Gontu, V. |
|
2009 |
15 |
Supplement 4 |
p. S57- 1 p. |
article |
64 |
P3.041 LINGO1 variant increases risk of familial essential tremor
|
Prakash, K.M. |
|
2009 |
15 |
Supplement 4 |
p. S158- 1 p. |
article |
65 |
P2.076 MANF: a new potential disease-modifying drug candidate for Parkinson's disease
|
Commissiong, J. |
|
2009 |
15 |
Supplement 4 |
p. S109- 1 p. |
article |
66 |
P1.072 Mapping motor and somatosensory cortical flnger representation in focal hand dystonia
|
Weise, D. |
|
2009 |
15 |
Supplement 4 |
p. S47- 1 p. |
article |
67 |
P3.089 Microglial MAC1 and PI3K are essential in mediating beta-amyloid peptide-induced neurotoxicity in neuron/glia cultures
|
Zhang, D. |
|
2009 |
15 |
Supplement 4 |
p. S171- 1 p. |
article |
68 |
P3.072 Mitochondrial NAD(H) suppliers rate-limit energy, signal transduction and redox-gradient spatio-temporal variables important for development and degeneration: lessons from Pellagra
|
Williams, A.C. |
|
2009 |
15 |
Supplement 4 |
p. S167- 1 p. |
article |
69 |
P2.062 MLPA analysis in EOP patients
|
Barzaghi, C. |
|
2009 |
15 |
Supplement 4 |
p. S105- 1 p. |
article |
70 |
P3.147 Neurodegenerative markers in CSF in patients suffering from Parkinson's disease
|
Vranová, H. |
|
2009 |
15 |
Supplement 4 |
p. S186- 1 p. |
article |
71 |
P2.008 Neuroprotective effect of GLP-1R agonist exendin-4 in rat model of Parkinson's disease involves D3-receptor mediated changes in neural precursor cells
|
Harkavyi, A. |
|
2009 |
15 |
Supplement 4 |
p. S90- 1 p. |
article |
72 |
P2.079 Neuroprotective properties of Poacynum against MPP+-toxicity to dopaminergic cells
|
Rausch, W.D. |
|
2009 |
15 |
Supplement 4 |
p. S110- 1 p. |
article |
73 |
P1.055 Open-label naturalistic study of pregabalin for cervical dystonia and other hyperkinetic movement disorders (HMDs): effectiveness and tolerability
|
Chen, J. |
|
2009 |
15 |
Supplement 4 |
p. S43- 1 p. |
article |
74 |
P1.127 Parkinson's disease subtypes and their relevance to studies of disease-modifying agents
|
Elm, J. |
|
2009 |
15 |
Supplement 4 |
p. S61- 1 p. |
article |
75 |
P3.014 Pellagra: American epidemic of a curable, familial, neurodegenerative, immune-deflcient, metabolic and bioenergetic “redox” disorder. Tip of NAD(H) iceberg?
|
Williams, A.C. |
|
2009 |
15 |
Supplement 4 |
p. S151- 1 p. |
article |
76 |
P3.017 Posterior alien hand phenomena as the flrst manifestation of HIV encephalopathy
|
Munhoz, R. |
|
2009 |
15 |
Supplement 4 |
p. S152- 1 p. |
article |
77 |
P2.138 Prevalence and improvement of comprehensive (non-motor) symptom assessment after prolonged-release ropinirole (Requip XL)
|
Isaacson, J. |
|
2009 |
15 |
Supplement 4 |
p. S127- 1 p. |
article |
78 |
P2.053 Primary Segmental Dystonia: 4 year follow-up of 11 patients treated with GPi deep brain stimulation
|
Sarubbo, S. |
|
2009 |
15 |
Supplement 4 |
p. S102-S103 2 p. |
article |
79 |
P1.188 Psychogenic movement disorders – a Brazilian series of 72 cases
|
Helio, T. |
|
2009 |
15 |
Supplement 4 |
p. S77- 1 p. |
article |
80 |
P2.141 Rasagiline provides symptomatic beneflt in early Parkinson's disease (PD)
|
Jankovic, J. |
|
2009 |
15 |
Supplement 4 |
p. S127-S128 2 p. |
article |
81 |
P1.130 Rater training on UPDRS: assessing raters' ratings
|
Gaur, R. |
|
2009 |
15 |
Supplement 4 |
p. S62- 1 p. |
article |
82 |
P2.018 Recapitulation of neurodegenerative disease and apoptotic neuronal cell death caused by 26S proteasome dysfunction
|
Rezvani, Z.N. |
|
2009 |
15 |
Supplement 4 |
p. S92-S93 2 p. |
article |
83 |
P1.096 Selective frontal atrophy of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP)
|
Kvickström, P. |
|
2009 |
15 |
Supplement 4 |
p. S53- 1 p. |
article |
84 |
P3.103 Serum iron levels are lower in Parkinson's disease patients as compared to controls and are modifled by haptoglobin phenotype
|
Costa-Mallen, P. |
|
2009 |
15 |
Supplement 4 |
p. S174- 1 p. |
article |
85 |
P2.209 Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease
|
Raisman Vozari, R. |
|
2009 |
15 |
Supplement 4 |
p. S146- 1 p. |
article |
86 |
P2.196 STN high frequency stimulation is effective in Parkinson's disease with camptocormia: a case report
|
Galazky, I. |
|
2009 |
15 |
Supplement 4 |
p. S143- 1 p. |
article |
87 |
P2.093 Switch from subcutaneous apomorphine to intraduodenal levodopa offers additional beneflt on motor fluctuations and dyskinesias in advanced Parkinson's disease
|
Tamburin, S. |
|
2009 |
15 |
Supplement 4 |
p. S114- 1 p. |
article |
88 |
P3.031 TaqI A polymorphism of dopamine D2 receptor gene (DRD2), dopamine dysregulation syndrome and impulse control disorders in Parkinson's disease
|
Gorzkowska, A. |
|
2009 |
15 |
Supplement 4 |
p. S156- 1 p. |
article |
89 |
P2.199 The national deep brain stimulation brain tissue network (DBS-BTN): preliminary results
|
Vedam-Mai, V. |
|
2009 |
15 |
Supplement 4 |
p. S143-S144 2 p. |
article |
90 |
P2.107 The protective effect of minocycline in 6-OHDA-induced toxicity in neuronal SH-SY5Y cells
|
Ossola, B. |
|
2009 |
15 |
Supplement 4 |
p. S118- 1 p. |
article |
91 |
P1.219 Traditional Chinese medicine improves activities of daily living in Parkinson's disease
|
Weidong, P. |
|
2009 |
15 |
Supplement 4 |
p. S85- 1 p. |
article |
92 |
P3.175 Transdermal lisuride is effective in Restless Legs Syndrome (RLS)
|
Beneŝs, H. |
|
2009 |
15 |
Supplement 4 |
p. S193- 1 p. |
article |
93 |
P3.120 Uncontrolled neuroinflammation drives progressive neurodegeneration in Parkinson's disease
|
Gao, H.-M. |
|
2009 |
15 |
Supplement 4 |
p. S179- 1 p. |
article |
94 |
P1.024 Verbal fluency and psychomotor speed in early Parkinson's disease: is there a link?
|
Hipp, G. |
|
2009 |
15 |
Supplement 4 |
p. S35- 1 p. |
article |
95 |
P3.055 Welding fume-related dopaminergic neurotoxicity
|
Sriram, K. |
|
2009 |
15 |
Supplement 4 |
p. S162- 1 p. |
article |
96 |
P1.185 Worry in Parkinson's disease: baseline data from the PROMS-PD cohort
|
Whitehead, D. |
|
2009 |
15 |
Supplement 4 |
p. S76- 1 p. |
article |
97 |
Rodent models of treatment-induced motor complications in Parkinson's disease
|
Cenci, M. Angela |
|
2009 |
15 |
Supplement 4 |
p. S13-S17 5 p. |
article |
98 |
Sleep dysfunction and role of dysautonomia in Parkinson's disease
|
Mitra, Tanya |
|
2009 |
15 |
Supplement 4 |
p. S93-S95 3 p. |
article |
99 |
Sleepiness in Parkinson's disease
|
Arnulf, Isabelle |
|
2009 |
15 |
Supplement 4 |
p. S101-S104 4 p. |
article |
100 |
Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life
|
Martinez-Martin, Pablo |
|
2009 |
15 |
Supplement 4 |
p. S58-S64 7 p. |
article |
101 |
The clinical progression of Parkinson's disease
|
Poewe, Werner |
|
2009 |
15 |
Supplement 4 |
p. S28-S32 5 p. |
article |
102 |
The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: A pilot study
|
Tassorelli, Cristina |
|
2009 |
15 |
Supplement 4 |
p. 675-681 7 p. |
article |
103 |
Toxic effects of dopamine metabolism in Parkinson's disease
|
Hattori, Nobutaka |
|
2009 |
15 |
Supplement 4 |
p. S35-S38 4 p. |
article |
104 |
Treatment of dysautonomia associated with Parkinson's disease
|
Mostile, Giovanni |
|
2009 |
15 |
Supplement 4 |
p. S224-S232 9 p. |
article |